Raynaud Phenomenon
📧 Sign up to get email alerts when something new happens for Raynaud Phenomenon.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-29Clinical Trial Results: Botulinum Toxin in Raynaud's Phenomenon [Phase 4]
Phase 4 clinical trial results evaluating botulinum toxin for Raynaud's Phenomenon have been completed and results posted.
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Open Label Treprostinil Raynaud's Study [Phase 4]
Open-label Phase 4 clinical trial of treprostinil for Raynaud's disease/phenomena is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Metabolomic Analysis of Systemic Sclerosis
The ClinicalTrials.gov update reports that the metabolomic analysis study of systemic sclerosis and related connective tissue diseases has b…
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: Potential Benefit for Non Invasive Vagus Nerve Stimulation Using GammaCore in the Treatment of Raynaud's Phenomena. [NA]
A terminated clinical trial evaluating non-invasive vagus nerve stimulation using gammaCore for Raynaud's phenomenon has posted results, ind…
-
CLINICAL_TRIALS trial_result · 2025-05-25Clinical Trial Update: Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2) [Phase 2]
This Phase 2 trial evaluated intravenous iloprost in subjects with Raynaud's phenomenon secondary to systemic sclerosis; results have been p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Multi-modal Quantitative Imaging of the Skin
Clinical trial update for a multi-modal quantitative imaging study of the skin, sponsored by HJN Sverige AB/Neko Health, currently recruitin…
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Early Diagnosis of SSc in the General Rheumatology Clinic - Pilot
A pilot study evaluating early diagnosis of systemic sclerosis in a general rheumatology clinic has been completed.
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: Apollo Device for Fatigue in Systemic Sclerosis [NA]
A completed clinical trial evaluated the Apollo Device for fatigue in systemic sclerosis. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: Botulinum Toxin in Raynaud's Phenomenon [Phase 4]
A Phase 4 clinical trial is investigating botulinum toxin for Raynaud Phenomenon and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Effects of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis [Phase 2]
Phase 2 trial evaluating selexipag for Raynaud's phenomenon in adults with systemic sclerosis. The study status is completed.
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Evaluation of Botulinum TOXin Type a in the Treatment of Buerger's Disease [Phase 3]
Phase 3 clinical trial evaluating botulinum toxin type A for Thromboangiitis Obliterans (Buerger's disease) and Raynaud phenomenon; the stud…
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: A Study to Investigate Safety of GS-248 and Efficacy on Raynauds' Phenomenon in Systemic Sclerosis [Phase 2]
Phase 2 trial evaluating GS-248 for safety and efficacy in Raynaud's phenomenon associated with systemic sclerosis has completed, with resul…
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Exparel as a Nerve Block for Severe Hand Pain [Phase 2, Phase 3]
Phase 2/3 trial of Exparel (liposomal bupivacaine) as a nerve block for severe hand pain in CREST syndrome and peripheral vascular disease w…
-
CLINICAL_TRIALS trial_result · 2023-12-22Clinical Trial Update: A Study to Assess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic Sclerosis [Phase 2]
Phase 2 trial evaluating oral Temanogrel for improving digital blood flow in adults with Raynaud's Phenomenon secondary to systemic sclerosi…
-
CLINICAL_TRIALS trial_result · 2023-05-18Clinical Trial Update: Cold Challenge With C21 in RP [Phase 2]
Phase 2 trial update on C21 for Raynaud Phenomenon and Systemic Sclerosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: Efficacy and Safety of Vascana® in Subjects With Secondary Raynaud's Phenomenon [Phase 2]
Phase 2 clinical trial update on the efficacy and safety of Vascana in subjects with Raynaud's phenomenon secondary to connective tissue dis…
-
CLINICAL_TRIALS trial_result · 2022-02-10Clinical Trial Update: Efficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic Sclerosis [Phase 3]
Phase 3 trial evaluating the efficacy of Botulinum Toxin A for Raynaud phenomenon secondary to systemic sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2021-06-30Clinical Trial Update: The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's Phenomenon [Phase 4]
Phase 4 trial investigating abobotulinum toxin A for Raynaud's Phenomenon; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2020-08-12Clinical Trial Update: Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma [Phase 2]
Phase 2 trial investigating atorvastatin for microvascular endothelial function and Raynaud phenomenon in early diffuse cutaneous systemic s…
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: Beet the Cold: The Effect of Inorganic Nitrate Supplementation in Individuals With Raynaud's Phenomenon [NA]
Clinical trial studying inorganic nitrate supplementation for Raynaud phenomenon has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-06-04Clinical Trial Update: Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR) [NA]
A completed clinical trial evaluated Celution processed adipose-derived regenerative cells (STAR) for treating scleroderma (systemic scleros…
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon [NA]
A clinical trial evaluating Diosmiplex (Vasculera) for primary and secondary Raynaud's phenomenon has completed. The study was sponsored by …
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: Efficacy and Tolerability of Ginkgo Biloba Extract in Patients With Raynaud´s Phenomenon [Phase 2]
Phase 2 trial reports on the efficacy and tolerability of Ginkgo Biloba Extract for Raynaud's phenomenon; results have been posted after com…
-
CLINICAL_TRIALS trial_result · 2017-01-23Clinical Trial Update: Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud [EARLY_Phase 1]
The document notes completion of an early Phase 1 trial comparing topical 10% nifedipine with 5% sildenafil for secondary Raynaud's phenomen…
-
CLINICAL_TRIALS trial_result · 2016-12-22Clinical Trial Update: Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome [Phase 3]
Phase 3 clinical trial completed evaluating the efficacy of botulinum toxin for scleroderma-associated Raynaud's phenomenon; results posted.